Robots in the OR: Mazor Robotics unveils its latest surgical robot | Regulatory Roundup

M and A Roundup

Mazor Robotics Ltd. (TASE:MZOR) unveiled its new Renaissance device, the next generation of its spinal robotic surgical guidance systems technology, which extend potential applications to more complex spine surgeries.

The new system is built on the core of the previous generation SpineAssist technology, which has been successfully used in more than 2,000 surgeries worldwide, accurately placing more than 12,000 implants, according to company officials.

The Israel-based company also touted positive findings from a 14-site international multicenter study published in the journal Spine, which showed that Mazor robotics technology "offers enhanced performance in spinal surgery when compared to freehand surgeries, by increasing placement accuracy and reducing neurologic risks," according to the release.

The Renaissance device features a new design and human interface, and well as updated hardware and software. The upgrades are designed to increase safety as well as extend potential surgical applications for the robot. The last generation could accomplish spinal fusions and scoliosis corrections, but the new generation can assist in osteotomies and implant placements.

Renaissance also serves as a platform that will support future clinical applications, such as robotic-guided cranial surgeries, according to the release.

The Renaissance systems already have U.S. regulatory clearance as well as CE Mark approval in the European Union. The company closed a $6.3 million PIPE funding round in February.

  • Masimo initiates limited release of E1 single-patient-use ear sensor
    Masimo Corp. (NSDQ:MASI) announced limited release of its single-patient-use ear sensor, the industry’s first according to the release. The device detects oxygen saturation changes in the blood using the ear as an alternative to a finger sensor. The device already boasts 510(k) clearance and CE Mark approval in the European Union.

    The launch is welcome news for the Irvine, Calif.-based company, which is currently mired in a proxy challenge regarding its executive compensation package.

    Read more
  • Staar Surgical touts two regulatory wins
    STAAR Surgical Company (NASDAQ: STAA) touted two regulatory approvals last week. The company landed CE Mark approval for its KS-SP acrylic intraocular lens, as well as Brazilian marketing approval for its Visian implantable Collamer lens. The Monrovia, Calif.-based company plans to launch both new products during the second half of 2011.

    Read more
  • Medisafe files three med-tech patents
    Medisafe 1 Technologies Corp. (OTCBB:MFTH) a developer of patented technologies that physically prevent unauthorized administration of prescription medications, announced that it is in the process of submitting three new patents for medical safety devices. The first prevents products from leaving inventory storage without authorization, the second is a new locking mechanism for syringes and capsules, and the third is a physical lock that measures release of prescribed dosages to prevent over-dosing. The company secured a $5 million equity investment with Centurion Private Equity, LLC in April.
    Read more
  • Pathway Medical lands 510(k) for Jetstream Navitus
    Pathway Medical Technologies Inc. announced U.S. regulatory clearance for its Jetstream Navitus catheter for treatment of peripheral vascular disease. The device is now available for sale in the U.S., according to the release.
    Read more
  • ArthroCare gets FDA nod for Spartan 6.5
    ArthroCare Corp. (NSDQ:ARTC) announced U.S. Food & Drug Administration clearance for its Spartan 6.5 needled anchor, a preloaded threaded anchor for fixation of soft tissue to bone. The Spartan 6.5 is intended for open repairs, whereas its non-needled cousin, which received FDA clearance in October 2010, is intended for arthroscopic repairs.

    Read more
  • 3Disc touts FDA win for FireCR scanner and QuantorMed imaging software
    3Disc, a computed radiography solution maker, touted 510(k) clearance for its FireCR medical scanners and QuantorMed imaging software. The company’s CR scanners and software can be quickly upgraded in the field without having to replace equipment, according to company officials.

    Read more
  • Nico wins Canadian approval for brain tumor removal system
    Nico Corp. announced that it received approval to market its Myriad brain tumor removal system in Canada. Myriad is a fully automated neuro and spinal tissue removal device about the size of a pencil, which allows surgeons to operate through a narrow opening, and operating without using heat or ultrasonic energy that can potentially damage nerve structures. The device won FDA clearance in 2009 and CE Mark in April.

    Read more
  • Datascope/Maquet announces voluntary field correction for certain intra-aortic balloon pumps
    Datascope Corp. and Maquet Cardiovascular LLC announced a voluntary field correction for their S98/98XT, CS100/CS100i and CS300 balloon pumps, a move that affects nearly 1,300 customers worldwide. Pumps manufactured between May 2008 and December 2010 may have an affected power supply, or may have received one during a service upgrade in the field. In specific units, the fan assembly in the power supply might have a misshapen retaining ring, which could disengage with the fan and cause the assembly to stop rotating.


    This looks like a bad year for Maquet, which underwent Class 1 FDA recall for some of its Heartstring II proximal seal systems in April.

    Read more
  • RSS From Medical Design & Outsourcing

    • Athermal laser machining cuts bioabsorbable polymers and more
      A the recent MD&M East trade show in New York, Norman Noble, discussed the capability of athermal laser manufacturer. The company has developed the Noble S.T.E.A.L.T.H. (System To Enable Ablation Laser Technology Haz-free). The athermal laser machining process was developed to create precise features in any material, including bioabsorbable polymers, shape memory metals and other […]
    • Exciting possibilities for metallic glass in the medical device world
      Researchers are exploring the potential of metallic glass as a versatile, pliable material that is stronger than steel, with a bevy of possible medical device applications. Yale University engineers have discovered a unique method for designing metallic glass nanostructures across a wide range of chemicals, a technique that could have applications for everything from watch […]
    • Strong Precision Technologies’ medical divisions to unify under MedTorque brand
      Strong Precision Technologies announced on July 2, 2015, that its two medical divisions will now go to market under a single brand, MedTorque. The move reflects the increasing integration of the division formerly known as Inland Midwest with MedTorque, its sister division in Kenosha, WI. “We will continue providing our customers with the personalized level of service […]
    • Olympus offers next-day product replacement guarantee for medical devices
      Olympus, a medical and surgical procedures solutions company, announced that it is guaranteeing next-day replacements for surgical equipment at no additional charge. Olympus is the first surgical product manufacturer to offer this type of guarantee. The service became available to customers with an Olympus Full Service Agreement earlier this year. “Canceled procedures can be costly for healthcare facilities […]
    • More accurate prediction on prognosis in multiple myeloma from SkylineDx
      SkylineDx, a biotechnology company specializing in the development and commercialization of genetic tests, is launching its MMprofiler assay. This test enables clinicians to more accurately predict the prognosis of patients with multiple myeloma (bone marrow cancer) than traditional methods. The MMprofiler measures the activity of 92 genes which are directly or indirectly related to the […]
    • Flint Mobile swaps card reader for camera, accept mobile payments anywhere
      Flint Mobile, the swipe-free mobile payments app, has significantly expanded its payment management and loyalty capabilities for small, service-centric businesses, like the ones run by on-the-go medical equipment professionals. The toggle-free mobile technology makes the process quite simple for both parties, as all transactions are conducted through the mobile device’s camera without the need of any external […]
    • Should scientists be allowed to genetically alter human embryos?
      Scientists have at their disposal, a way to explore the possible prevention of genetic diseases before birth. But should they? Currently, the most promising path forward involves editing the genes of human embryos, a procedure threaded with controversy. An article in “Chemical & Engineering News” (C&EN), the weekly newsmagazine of the American Chemical Society (ACS), parses […]
    • Tackling chronic sinusitis by addressing underlying factors
      The stuffy noses and sinus pressure of head colds are uncomfortable, but for most people, they go away within days. For those with chronic sinusitis, however, those symptoms and others drag on for weeks. Now scientists are onto a potential new therapy that could address one of the underlying factors associated with the condition. They […]
    • Implantable “artificial pancreas” could help diabetes patients control their blood sugar
      Living with Type 1 diabetes requires constant monitoring of blood sugar levels and injecting insulin daily. Now scientists are reporting in the American Chemical Society (ACS) journal, “Industrial & Engineering Chemistry Research,” the development of an implantable “artificial pancreas” that continuously measures a person’s blood sugar or glucose level and can automatically release insulin as […]
    • Drug Deactivation program roll out to all facilities for safe disposal of unused prescription medications
      Verde Technologies announced that New Brighton-based Meridian Behavioral Health, the largest for-profit substance abuse and addiction treatment group in Minnesota, has become its most recent partner in the deactivation and safe disposal of prescription medications including methadone. Meridian is the first behavioral health group to roll out the Deterra Drug Deactivation System to all 17 […]
    • Lophius Biosciences introduces T-activated ImmunoScan Cocktail
      Lophius Biosciences announced the commercial launch of T-Track ImmunoScan and T-activated ImmunoScan Cocktail. Based on a proprietary and very specific cocktail of stimulants in combination with the Company’s T-activation technology, T-Track ImmunoScan and T-activated ImmunoScan Cocktail specifically target different cell types involved in both the adaptive and innate immune system. T-Track ImmunoScan and the T-activated […]

    Leave a Reply